aluates Reports

$ 0.0

Automative

Global Continuous Manufacturing in Pharmaceutical Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-7G13264

Global Continuous Manufacturing in Pharmaceutical Market Research Report 2023

BUY CHAPTERS

Global Continuous Manufacturing in Pharmaceutical Market Research Report 2025

Code: QYRE-Auto-7G13264

Report

May 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Siemens AG

Syntegon

Corning Inc

GEA

KORSCH

Chemtrix

L.B. Bohle

SL Controls

Continuus Pharmaceuticals

Hovione

IMA Group

Dec Group

SK pharmteco

Pharmira

Continuous Manufacturing in Pharmaceutical Market Size

The global market for Continuous Manufacturing in Pharmaceutical was valued at US$ 759 million in the year 2024 and is projected to reach a revised size of US$ 1484 million by 2031, growing at a CAGR of 10.2% during the forecast period.

Continuous Manufacturing in Pharmaceutical Market

Continuous manufacturing involves a pharmaceutical product being produced nonstop in one continuous manufacturing process. The entire process takes place in one facility, start to finish, without hold times.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Continuous Manufacturing in Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Manufacturing in Pharmaceutical.

The Continuous Manufacturing in Pharmaceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Continuous Manufacturing in Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Continuous Manufacturing in Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Continuous Manufacturing in Pharmaceutical Market Report

Report Metric	Details
Report Name	Continuous Manufacturing in Pharmaceutical Market
Accounted market size in year	US$ 759 million
Forecasted market size in 2031	US$ 1484 million
CAGR	10.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Powder Tablet Capsule Injection Others
Segment by Application	In-house CMO CDMO
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Siemens, Syntegon, Corning, GEA, SK pharmteco, Korsch, Chemtrix, L.B. Bohle, Pharmira, SL Controls, CONTINUUS Pharmaceuticals, Hovione, IMA Group, Dec Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Manufacturing in Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Continuous Manufacturing in Pharmaceutical Market growing?

Ans: The Continuous Manufacturing in Pharmaceutical Market witnessing a CAGR of 10.2% during the forecast period 2025-2031.

What is the Continuous Manufacturing in Pharmaceutical Market size in 2031?

Ans: The Continuous Manufacturing in Pharmaceutical Market size in 2031 will be US$ 1484 million.

Who are the main players in the Continuous Manufacturing in Pharmaceutical Market report?

Ans: The main players in the Continuous Manufacturing in Pharmaceutical Market are Siemens, Syntegon, Corning, GEA, SK pharmteco, Korsch, Chemtrix, L.B. Bohle, Pharmira, SL Controls, CONTINUUS Pharmaceuticals, Hovione, IMA Group, Dec Group

What are the Application segmentation covered in the Continuous Manufacturing in Pharmaceutical Market report?

Ans: The Applications covered in the Continuous Manufacturing in Pharmaceutical Market report are In-house, CMO, CDMO

What are the Type segmentation covered in the Continuous Manufacturing in Pharmaceutical Market report?

Ans: The Types covered in the Continuous Manufacturing in Pharmaceutical Market report are Powder, Tablet, Capsule, Injection, Others

Recommended Reports

Pharma Equipment

Pharma Services

Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Continuous Manufacturing in Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Powder

1.2.3 Tablet

1.2.4 Capsule

1.2.5 Injection

1.2.6 Others

1.3 Market by Application

1.3.1 Global Continuous Manufacturing in Pharmaceutical Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 In-house

1.3.3 CMO

1.3.4 CDMO

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Continuous Manufacturing in Pharmaceutical Market Perspective (2020-2031)

2.2 Global Continuous Manufacturing in Pharmaceutical Growth Trends by Region

2.2.1 Global Continuous Manufacturing in Pharmaceutical Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Continuous Manufacturing in Pharmaceutical Historic Market Size by Region (2020-2025)

2.2.3 Continuous Manufacturing in Pharmaceutical Forecasted Market Size by Region (2026-2031)

2.3 Continuous Manufacturing in Pharmaceutical Market Dynamics

2.3.1 Continuous Manufacturing in Pharmaceutical Industry Trends

2.3.2 Continuous Manufacturing in Pharmaceutical Market Drivers

2.3.3 Continuous Manufacturing in Pharmaceutical Market Challenges

2.3.4 Continuous Manufacturing in Pharmaceutical Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Continuous Manufacturing in Pharmaceutical Players by Revenue

3.1.1 Global Top Continuous Manufacturing in Pharmaceutical Players by Revenue (2020-2025)

3.1.2 Global Continuous Manufacturing in Pharmaceutical Revenue Market Share by Players (2020-2025)

3.2 Global Continuous Manufacturing in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Continuous Manufacturing in Pharmaceutical Revenue

3.4 Global Continuous Manufacturing in Pharmaceutical Market Concentration Ratio

3.4.1 Global Continuous Manufacturing in Pharmaceutical Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Continuous Manufacturing in Pharmaceutical Revenue in 2024

3.5 Global Key Players of Continuous Manufacturing in Pharmaceutical Head office and Area Served

3.6 Global Key Players of Continuous Manufacturing in Pharmaceutical, Product and Application

3.7 Global Key Players of Continuous Manufacturing in Pharmaceutical, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Continuous Manufacturing in Pharmaceutical Breakdown Data by Type

4.1 Global Continuous Manufacturing in Pharmaceutical Historic Market Size by Type (2020-2025)

4.2 Global Continuous Manufacturing in Pharmaceutical Forecasted Market Size by Type (2026-2031)

5 Continuous Manufacturing in Pharmaceutical Breakdown Data by Application

5.1 Global Continuous Manufacturing in Pharmaceutical Historic Market Size by Application (2020-2025)

5.2 Global Continuous Manufacturing in Pharmaceutical Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Continuous Manufacturing in Pharmaceutical Market Size (2020-2031)

6.2 North America Continuous Manufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025)

6.4 North America Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Continuous Manufacturing in Pharmaceutical Market Size (2020-2031)

7.2 Europe Continuous Manufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025)

7.4 Europe Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Size (2020-2031)

8.2 Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Size by Region (2020-2025)

8.4 Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Continuous Manufacturing in Pharmaceutical Market Size (2020-2031)

9.2 Latin America Continuous Manufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025)

9.4 Latin America Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Size (2020-2031)

10.2 Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025)

10.4 Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Siemens

11.1.1 Siemens Company Details

11.1.2 Siemens Business Overview

11.1.3 Siemens Continuous Manufacturing in Pharmaceutical Introduction

11.1.4 Siemens Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.1.5 Siemens Recent Development

11.2 Syntegon

11.2.1 Syntegon Company Details

11.2.2 Syntegon Business Overview

11.2.3 Syntegon Continuous Manufacturing in Pharmaceutical Introduction

11.2.4 Syntegon Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.2.5 Syntegon Recent Development

11.3 Corning

11.3.1 Corning Company Details

11.3.2 Corning Business Overview

11.3.3 Corning Continuous Manufacturing in Pharmaceutical Introduction

11.3.4 Corning Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.3.5 Corning Recent Development

11.4 GEA

11.4.1 GEA Company Details

11.4.2 GEA Business Overview

11.4.3 GEA Continuous Manufacturing in Pharmaceutical Introduction

11.4.4 GEA Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.4.5 GEA Recent Development

11.5 SK pharmteco

11.5.1 SK pharmteco Company Details

11.5.2 SK pharmteco Business Overview

11.5.3 SK pharmteco Continuous Manufacturing in Pharmaceutical Introduction

11.5.4 SK pharmteco Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.5.5 SK pharmteco Recent Development

11.6 Korsch

11.6.1 Korsch Company Details

11.6.2 Korsch Business Overview

11.6.3 Korsch Continuous Manufacturing in Pharmaceutical Introduction

11.6.4 Korsch Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.6.5 Korsch Recent Development

11.7 Chemtrix

11.7.1 Chemtrix Company Details

11.7.2 Chemtrix Business Overview

11.7.3 Chemtrix Continuous Manufacturing in Pharmaceutical Introduction

11.7.4 Chemtrix Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.7.5 Chemtrix Recent Development

11.8 L.B. Bohle

11.8.1 L.B. Bohle Company Details

11.8.2 L.B. Bohle Business Overview

11.8.3 L.B. Bohle Continuous Manufacturing in Pharmaceutical Introduction

11.8.4 L.B. Bohle Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.8.5 L.B. Bohle Recent Development

11.9 Pharmira

11.9.1 Pharmira Company Details

11.9.2 Pharmira Business Overview

11.9.3 Pharmira Continuous Manufacturing in Pharmaceutical Introduction

11.9.4 Pharmira Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.9.5 Pharmira Recent Development

11.10 SL Controls

11.10.1 SL Controls Company Details

11.10.2 SL Controls Business Overview

11.10.3 SL Controls Continuous Manufacturing in Pharmaceutical Introduction

11.10.4 SL Controls Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.10.5 SL Controls Recent Development

11.11 CONTINUUS Pharmaceuticals

11.11.1 CONTINUUS Pharmaceuticals Company Details

11.11.2 CONTINUUS Pharmaceuticals Business Overview

11.11.3 CONTINUUS Pharmaceuticals Continuous Manufacturing in Pharmaceutical Introduction

11.11.4 CONTINUUS Pharmaceuticals Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.11.5 CONTINUUS Pharmaceuticals Recent Development

11.12 Hovione

11.12.1 Hovione Company Details

11.12.2 Hovione Business Overview

11.12.3 Hovione Continuous Manufacturing in Pharmaceutical Introduction

11.12.4 Hovione Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.12.5 Hovione Recent Development

11.13 IMA Group

11.13.1 IMA Group Company Details

11.13.2 IMA Group Business Overview

11.13.3 IMA Group Continuous Manufacturing in Pharmaceutical Introduction

11.13.4 IMA Group Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.13.5 IMA Group Recent Development

11.14 Dec Group

11.14.1 Dec Group Company Details

11.14.2 Dec Group Business Overview

11.14.3 Dec Group Continuous Manufacturing in Pharmaceutical Introduction

11.14.4 Dec Group Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

11.14.5 Dec Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Siemens AG

Syntegon

Corning Inc

GEA

KORSCH

Chemtrix

L.B. Bohle

SL Controls

Continuus Pharmaceuticals

Hovione

IMA Group

Dec Group

SK pharmteco

Pharmira

List of Tables

Table 1. Global Continuous Manufacturing in Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Powder

Table 3. Key Players of Tablet

Table 4. Key Players of Capsule

Table 5. Key Players of Injection

Table 6. Key Players of Others

Table 7. Global Continuous Manufacturing in Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Continuous Manufacturing in Pharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Continuous Manufacturing in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Continuous Manufacturing in Pharmaceutical Market Share by Region (2020-2025)

Table 11. Global Continuous Manufacturing in Pharmaceutical Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Continuous Manufacturing in Pharmaceutical Market Share by Region (2026-2031)

Table 13. Continuous Manufacturing in Pharmaceutical Market Trends

Table 14. Continuous Manufacturing in Pharmaceutical Market Drivers

Table 15. Continuous Manufacturing in Pharmaceutical Market Challenges

Table 16. Continuous Manufacturing in Pharmaceutical Market Restraints

Table 17. Global Continuous Manufacturing in Pharmaceutical Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Continuous Manufacturing in Pharmaceutical Market Share by Players (2020-2025)

Table 19. Global Top Continuous Manufacturing in Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Manufacturing in Pharmaceutical as of 2024)

Table 20. Ranking of Global Top Continuous Manufacturing in Pharmaceutical Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Continuous Manufacturing in Pharmaceutical Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Continuous Manufacturing in Pharmaceutical, Headquarters and Area Served

Table 23. Global Key Players of Continuous Manufacturing in Pharmaceutical, Product and Application

Table 24. Global Key Players of Continuous Manufacturing in Pharmaceutical, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Continuous Manufacturing in Pharmaceutical Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Continuous Manufacturing in Pharmaceutical Revenue Market Share by Type (2020-2025)

Table 28. Global Continuous Manufacturing in Pharmaceutical Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Continuous Manufacturing in Pharmaceutical Revenue Market Share by Type (2026-2031)

Table 30. Global Continuous Manufacturing in Pharmaceutical Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Continuous Manufacturing in Pharmaceutical Revenue Market Share by Application (2020-2025)

Table 32. Global Continuous Manufacturing in Pharmaceutical Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Continuous Manufacturing in Pharmaceutical Revenue Market Share by Application (2026-2031)

Table 34. North America Continuous Manufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Continuous Manufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Continuous Manufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)

Table 49. Siemens Company Details

Table 50. Siemens Business Overview

Table 51. Siemens Continuous Manufacturing in Pharmaceutical Product

Table 52. Siemens Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 53. Siemens Recent Development

Table 54. Syntegon Company Details

Table 55. Syntegon Business Overview

Table 56. Syntegon Continuous Manufacturing in Pharmaceutical Product

Table 57. Syntegon Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 58. Syntegon Recent Development

Table 59. Corning Company Details

Table 60. Corning Business Overview

Table 61. Corning Continuous Manufacturing in Pharmaceutical Product

Table 62. Corning Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 63. Corning Recent Development

Table 64. GEA Company Details

Table 65. GEA Business Overview

Table 66. GEA Continuous Manufacturing in Pharmaceutical Product

Table 67. GEA Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 68. GEA Recent Development

Table 69. SK pharmteco Company Details

Table 70. SK pharmteco Business Overview

Table 71. SK pharmteco Continuous Manufacturing in Pharmaceutical Product

Table 72. SK pharmteco Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 73. SK pharmteco Recent Development

Table 74. Korsch Company Details

Table 75. Korsch Business Overview

Table 76. Korsch Continuous Manufacturing in Pharmaceutical Product

Table 77. Korsch Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 78. Korsch Recent Development

Table 79. Chemtrix Company Details

Table 80. Chemtrix Business Overview

Table 81. Chemtrix Continuous Manufacturing in Pharmaceutical Product

Table 82. Chemtrix Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 83. Chemtrix Recent Development

Table 84. L.B. Bohle Company Details

Table 85. L.B. Bohle Business Overview

Table 86. L.B. Bohle Continuous Manufacturing in Pharmaceutical Product

Table 87. L.B. Bohle Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 88. L.B. Bohle Recent Development

Table 89. Pharmira Company Details

Table 90. Pharmira Business Overview

Table 91. Pharmira Continuous Manufacturing in Pharmaceutical Product

Table 92. Pharmira Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 93. Pharmira Recent Development

Table 94. SL Controls Company Details

Table 95. SL Controls Business Overview

Table 96. SL Controls Continuous Manufacturing in Pharmaceutical Product

Table 97. SL Controls Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 98. SL Controls Recent Development

Table 99. CONTINUUS Pharmaceuticals Company Details

Table 100. CONTINUUS Pharmaceuticals Business Overview

Table 101. CONTINUUS Pharmaceuticals Continuous Manufacturing in Pharmaceutical Product

Table 102. CONTINUUS Pharmaceuticals Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 103. CONTINUUS Pharmaceuticals Recent Development

Table 104. Hovione Company Details

Table 105. Hovione Business Overview

Table 106. Hovione Continuous Manufacturing in Pharmaceutical Product

Table 107. Hovione Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 108. Hovione Recent Development

Table 109. IMA Group Company Details

Table 110. IMA Group Business Overview

Table 111. IMA Group Continuous Manufacturing in Pharmaceutical Product

Table 112. IMA Group Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 113. IMA Group Recent Development

Table 114. Dec Group Company Details

Table 115. Dec Group Business Overview

Table 116. Dec Group Continuous Manufacturing in Pharmaceutical Product

Table 117. Dec Group Revenue in Continuous Manufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)

Table 118. Dec Group Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

Table 122. Authors List of This Report

List of Figures

Figure 1. Continuous Manufacturing in Pharmaceutical Picture

Figure 2. Global Continuous Manufacturing in Pharmaceutical Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Continuous Manufacturing in Pharmaceutical Market Share by Type: 2024 VS 2031

Figure 4. Powder Features

Figure 5. Tablet Features

Figure 6. Capsule Features

Figure 7. Injection Features

Figure 8. Others Features

Figure 9. Global Continuous Manufacturing in Pharmaceutical Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Continuous Manufacturing in Pharmaceutical Market Share by Application: 2024 VS 2031

Figure 11. In-house Case Studies

Figure 12. CMO Case Studies

Figure 13. CDMO Case Studies

Figure 14. Continuous Manufacturing in Pharmaceutical Report Years Considered

Figure 15. Global Continuous Manufacturing in Pharmaceutical Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Continuous Manufacturing in Pharmaceutical Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Continuous Manufacturing in Pharmaceutical Market Share by Region: 2024 VS 2031

Figure 18. Global Continuous Manufacturing in Pharmaceutical Market Share by Players in 2024

Figure 19. Global Top Continuous Manufacturing in Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Manufacturing in Pharmaceutical as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Continuous Manufacturing in Pharmaceutical Revenue in 2024

Figure 21. North America Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Continuous Manufacturing in Pharmaceutical Market Share by Country (2020-2031)

Figure 23. United States Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Continuous Manufacturing in Pharmaceutical Market Share by Country (2020-2031)

Figure 27. Germany Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Continuous Manufacturing in Pharmaceutical Market Share by Region (2020-2031)

Figure 35. China Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Continuous Manufacturing in Pharmaceutical Market Share by Country (2020-2031)

Figure 43. Mexico Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Continuous Manufacturing in Pharmaceutical Market Share by Country (2020-2031)

Figure 47. Turkey Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Continuous Manufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Siemens Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 51. Syntegon Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 52. Corning Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 53. GEA Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 54. SK pharmteco Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 55. Korsch Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 56. Chemtrix Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 57. L.B. Bohle Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 58. Pharmira Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 59. SL Controls Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 60. CONTINUUS Pharmaceuticals Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 61. Hovione Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 62. IMA Group Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 63. Dec Group Revenue Growth Rate in Continuous Manufacturing in Pharmaceutical Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Continuous Pharma Production Lines Market Research Report 2024

Global Continuous Processing Lines for Pharma Market Research Report 2024

Global Pharma Continuous Granulation Market Research Report 2024

Global Continuous Manufacturing Market Research Report 2024

Pharmaceutical Contract Manufacturing and Contract Market

Global Pharmaceutical Manufacturing and Processing Equipment Market Research Report 2024

Global Pharmaceutical Flexible Manufacturing Systems Market Research Report 2025

Healthcare Contract Development And Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Pharmaceutical Manufacturing Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

3D Printing in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Manufacturing Equipment Market Insights Forecast to 2030

Global Pharma Continuous Blender Market Research Report 2024

Global Pharmaceutical Manufacturing Software Market Insights Forecast to 2030

Global Drug Manufacturing Equipment Market Research Report 2024

Global Pharmaceutical Production Equipment Market Research Report 2024

Pharmaceutical Processing Seals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IoT Spending for Connected Devices Platforms Digital Services in Pharmaceutical Manufacturing Market Insights Forecast to 2030

Global Commercial Drug Manufacturing Service Market Research Report 2025

Pharmaceutical Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions